Yung Hsiang Lin
Chief Executive Officer at TCI CO., LTD.
Net worth: 12 M $ as of 2024-03-30
Profile
Yung Hsiang Lin is currently the Chairman & General Manager at TCI Co., Ltd.
since 2017 and at TCI GENE, Inc. since 2014.
He is also a Director at TCI Firstek Corp.
and the President of Shanghai Biotech Co., Ltd.
Mr. Lin completed his undergraduate degree at National Chung Hsing University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
TCI CO., LTD.
2.06% | 2022-09-29 | 2,441,405 ( 2.06% ) | 12 M $ | 2024-03-30 |
Yung Hsiang Lin active positions
Companies | Position | Start |
---|---|---|
TCI CO., LTD. | Chief Executive Officer | 2005-03-31 |
TCI GENE INC. | Chief Executive Officer | 2012-05-16 |
TCI Firstek Corp. | Director/Board Member | - |
Shanghai Biotech Co., Ltd.
Shanghai Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of TCI Co., Ltd., Shanghai Biotech Co., Ltd. is a private company that manufactures pharmaceuticals and cosmetics. The company is based in Shanghai, China. | President | - |
Training of Yung Hsiang Lin
National Chung Hsing University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
TCI CO., LTD. | Health Technology |
TCI GENE INC. | Health Services |
Private companies | 2 |
---|---|
Shanghai Biotech Co., Ltd.
Shanghai Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of TCI Co., Ltd., Shanghai Biotech Co., Ltd. is a private company that manufactures pharmaceuticals and cosmetics. The company is based in Shanghai, China. | Health Technology |
TCI Firstek Corp. |
- Stock Market
- Insiders
- Yung Hsiang Lin